Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-d-glucose) in vitro

International Immunopharmacology

Volumn 8, Issue 7, 2008, Pages 1059-1064

  Zhao, Lei ^a   Zhang, Shu Ling ^a   Tao, Jun Yan ^b   Pang, Ran ^a   Jin, Feng ^a   Guo, Yuan Jin ^a   Dong, Ji Hua ^a   Ye, Pian ^a   Zhao, Hong Yang ^a   Zheng, Guo Hua ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Corilagin; HO 1; NF kappaB; Pro inflammatory cytokines; RAW 264.7 cell line

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CORILAGIN; CYCLOOXYGENASE 2; DEXAMETHASONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXPERIMENTAL MODEL; GENE EXPRESSION; GRIESS TEST; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTRACELLULAR TRANSPORT; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; CYTOKINES; GLUCOSIDES; HEME OXYGENASE-1; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; NITRIC OXIDE; RNA, MESSENGER;

EID: 43449124391     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.03.003     Document Type: Article

References (29)

1. Shen Z.Q., Dong Z.J., Peng H., and Liu J.K. Modulation of PAI-1 and tPA activity and thrombolytic effects of corilagin. Planta Med 69 (2003) 1109-1112
2. Duan W., Yu Y., and Zhang L. Antiatherogenic effects of phyllanthus emblica associated with corilagin and its analogue. Yakugaku Zasshi 125 (2005) 587-591
3. Kinoshita S., Inoue Y., Nakama S., Ichiba T., and Aniya Y. Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin. Phytomedicine 14 (2007) 755-762
4. Cheng J.T., Lin T.C., and Hsu F.L. Antihypertensive effect of corilagin in the rat. Can J Physiol Pharm 73 (1995) 1425-1429
5. Shiota S., Shimizu M., Sugiyama J., Morita Y., Mizushima T., and Tsuchiya T. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 48 (2004) 67-73
6. Okabe S., Suganuma M., Imayoshi Y., Taniguchi S., Yoshida T., and Fujiki H. New TNF-alpha releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki. Biol Pharm Bull 24 (2001) 1145-1148
7. Marklova E. Inflammation and genes. Acta Medica (Hradec Kralove) 50 1 (2007) 17-21
8. Kim K.M., Kwon Y.G., Chung H.T., Yun Y.G., Pae H.O., Han J.A., et al. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol Appl Pharmacol 190 (2003) 1-8
9. Oshina H., Sotome S., Yoshii T., Torigoe I., Sugata Y., Maehara H., et al. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Bone 41 (2007) 575-583
10. Shao B.M., Xu W., Dai H., Tu P., Li Z., and Gao X.M. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun 320 (2004) 1103-1111
11. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
12. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
13. Burger D., Dayer J.M., Palmer G., and Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis?. Best Pract Res Clin Rheumatol 20 (2006) 879-896
14. Rose-John S., Waetzig G.H., Scheller J., Grotzinger J., and Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11 (2007) 613-624
15. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38 (2006) 1654-1661
16. Korhonen R., Lahti A., Kankaanranta H., and Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4 (2005) 471-479
17. Ryter S.W., Kim H.P., Hoetzel A., Park J.W., Nakahira K., Wang X., et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9 (2007) 49-89
18. Brasier A.R. The NF-kappaB regulatory network. Cardiovasc Toxicol 6 (2006) 111-130
19. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 72 (2006) 1605-1621
20. Cavaillon J.M., and Adib-Conquy M. Determining the degree of immunodysregulation in sepsis. Contrib Nephrol 156 (2007) 101-111
21. Harizi H., and Gualde N. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell Mol Immunol 3 (2006) 271-277
22. Franchimont D., Martens H., Hagelstein M.T., Louis E., Dewe W., Chrousos G.P., et al. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84 (1999) 2834-2839
23. Stocker R., and Perrella M.A. Heme oxygenase-1: a novel drug target for atherosclerotic diseases?. Circulation 114 (2006) 2178-2189
24. Abraham N.G., Asija A., Drummond G., and Peterson S. Heme oxygenase -1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther 7 (2007) 89-108
25. Prawan A., Kundu J.K., and Surh Y.J. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal 7 (2005) 1688-1703
26. Zhao L., Tao J.Y., Zhang S.L., Pang R., Jin F., Dong J.H., et al. Anti-inflammatory mechanism of Rungia pectinata (Linn.) Nees. Immunopharmacol Immunotoxicol 30 (2008) 135-151
27. Zhao L., Tao J.Y., Zhang S.L., Pang R., Jin F., Dong J.H., et al. Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb. Inflammation 30 (2007) 213-223
28. Ding Y., Zhao L., Mei H., Huang Z.H., and Zhang S.L. Alterations of biliary biochemical constituents and cytokines in infantile hepatitis syndrome. World J Gastroenterol 12 (2006) 7038-7041
29. Ding Y., Zhao L., Mei H., Zhang S.L., and Huang Z.H. Role of myeloid human cytomegalovirus infection in children's idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 24 (2007) 179-188